by Tulane University Credit: CC0 Public DomainWhen SARS-CoV-2 enters the human body, the virus’ spike protein binds to a cell, allowing the virus to infiltrate and begin replicating. A new study from Tulane University, conducted in partnership with Florida International University and published in Protein Science, has identified a protein that may be the glue that...
Science Press Trust of India Updated: January 03, 2023 12:22 pm IST The SARS-CoV-2 virus spreads to the brain, and lingers for almost eight months (Representational)Washington: The SARS-CoV-2 virus spreads throughout the body, including the brain, and lingers for almost eight months, shows an analysis of tissue samples from the autopsies of people who died...
OCTOBER 25TH, 2022 CONN HASTINGS GENETICS, MEDICINE, PUBLIC HEALTH Scientists at Oregon State University have developed a new treatment for COVID-19. The technology is based on mRNA, which has also been put to good use in COVID-19 vaccines. However, in this instance, the delivered mRNA encodes for human angiotensin-converting enzyme 2 (hACE2), which is the binding...
OCTOBER 25TH, 2022 CONN HASTINGS GENETICS, MEDICINE, PUBLIC HEALTH Scientists at Oregon State University have developed a new treatment for COVID-19. The technology is based on mRNA, which has also been put to good use in COVID-19 vaccines. However, in this instance, the delivered mRNA encodes for human angiotensin-converting enzyme 2 (hACE2), which is the binding...
FEBRUARY 3RD, 2021 MEDGADGET EDITORS MEDICINE, PUBLIC HEALTH Although a few types of COVID-19 vaccines have begun to be distributed around the world, a unique technology, developed at University of California, San Francisco, may offer an even more direct way to prevent the coronavirus from multiplying within the body. The UCSF team created a synthetic antibody that prevents...
